{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:38:05Z","timestamp":1791239885115,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL098669"],"award-info":[{"award-number":["HL098669"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL102597"],"award-info":[{"award-number":["HL102597"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL105406"],"award-info":[{"award-number":["R01HL105406"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Institutions"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.niox.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T12:48:40Z","timestamp":1529412520000},"page":"113-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease"],"prefix":"10.1016","volume":"78","author":[{"given":"Xiaohong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruru","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4059-7847","authenticated-orcid":false,"given":"Yingjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2018.06.004_bib1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.ATV.0000081742.92006.59","article-title":"Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase","volume":"23","author":"Achan","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2018.06.004_bib2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/heartjnl-2014-305509","article-title":"Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valve","volume":"100","author":"Ali","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.niox.2018.06.004_bib3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cardfail.2012.10.011","article-title":"The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy","volume":"18","author":"Anderssohn","year":"2012","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.niox.2018.06.004_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1479164110366053","article-title":"Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus","volume":"7","author":"Anderssohn","year":"2010","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.niox.2018.06.004_bib5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.CIR.0000051466.00227.13","article-title":"Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia","volume":"107","author":"Arrigoni","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib6","doi-asserted-by":"crossref","first-page":"21120","DOI":"10.1016\/S0021-9258(19)36901-7","article-title":"Macrophage nitric oxide synthase subunits. Purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme","volume":"268","author":"Baek","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.06.004_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/416337a","article-title":"Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms","volume":"416","author":"Barouch","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.niox.2018.06.004_bib8","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0735-1097(00)01013-5","article-title":"An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes","volume":"36","author":"Boger","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.niox.2018.06.004_bib9","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.108.838268","article-title":"Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community","volume":"119","author":"B\u00f6ger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/jn\/134.10.2842S","article-title":"Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the \"L-arginine paradox\" and acts as a novel cardiovascular risk factor","volume":"134","author":"B\u00f6ger","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.niox.2018.06.004_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.108.846402","article-title":"Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice","volume":"120","author":"Burger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1074\/jbc.M603606200","article-title":"Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function","volume":"282","author":"Cardounel","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.06.004_bib13","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1074\/jbc.M410241200","article-title":"Endogenous methylarginine modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl-and dimethylarginine in the presence and absence of tetrahydrobiopterin","volume":"280","author":"Cardounel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.06.004_bib14","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1089\/ars.2012.4824","article-title":"Nitric oxide synthases in heart failure","volume":"18","author":"Carnicer","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.niox.2018.06.004_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2143\/AC.63.1.2025329","article-title":"Asymmetrical dimethylarginine level in atrial fibrillation","volume":"63","author":"Cengel","year":"2008","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.niox.2018.06.004_bib16","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.111.186072","article-title":"Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease","volume":"59","author":"Chen","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.niox.2018.06.004_bib17","doi-asserted-by":"crossref","first-page":"H2212","DOI":"10.1152\/ajpheart.00224.2005","article-title":"Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts","volume":"289","author":"Chen","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.niox.2018.06.004_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1152\/physiolgenomics.00022.2003","article-title":"Alterations of gene expression in failing myocardium following left ventricular assist device support","volume":"14","author":"Chen","year":"2003","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.niox.2018.06.004_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.CIR.0000021120.90970.B9","article-title":"Nitric oxide modulates myocardial oxygen consumption in the failing heart","volume":"106","author":"Chen","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib20","doi-asserted-by":"crossref","first-page":"H1513","DOI":"10.1152\/ajpheart.00529.2001","article-title":"Effect of PDE5 inhibition on coronary hemodynamics in pacing-induced heart failure","volume":"284","author":"Chen","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.niox.2018.06.004_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/niox.1996.0106","article-title":"Interference of l-arginine analogues with l-arginine transport mediated by the y\u2009+\u2009Carrier hCAT-2B","volume":"1","author":"Closs","year":"1997","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2018.06.004_bib22","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1172\/JCI650","article-title":"Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensiverats","volume":"101","author":"Cosentino","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.niox.2018.06.004_bib23","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1126\/science.279.5359.2121","article-title":"Structure of nitric oxide synthase oxygenase dimer with pterin and substrate","volume":"279","author":"Crane","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.niox.2018.06.004_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.10","article-title":"Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"97","author":"Dasgupta","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.niox.2018.06.004_bib25","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1161\/01.CIR.0000101924.04515.2E","article-title":"Dimethylargininedimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence","volume":"108","author":"Dayoub","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib26","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1161\/CIRCULATIONAHA.114.015064","article-title":"Endothelial DDAH1 is an important regulator of angiogenesis but does not regulate vascular reactivity or hemodynamic homeostasis","volume":"131","author":"Dowsett","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib27","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/ATVBAHA.107.147595","article-title":"Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure","volume":"27","author":"D\u00fcckelmann","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2018.06.004_bib28","series-title":"Braunwald's Heart Disease: a Textbook of Cardiovascular Medicine","article-title":"Care of patients with end-stage heart disease","author":"Emanuel","year":"2011"},{"key":"10.1016\/j.niox.2018.06.004_bib29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/01.RES.0000100390.68771.CC","article-title":"Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice","volume":"93","author":"Feil","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2018.06.004_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-012-9323-1","article-title":"Soluble guanylate cyclase: a potential therapeutic target for heart failure","volume":"18","author":"Gheorghiade","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.niox.2018.06.004_bib31","doi-asserted-by":"crossref","first-page":"28938","DOI":"10.1074\/jbc.M110.154948","article-title":"Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure","volume":"285","author":"Gonzalez","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.06.004_bib32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(96)90610-8","article-title":"Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy","volume":"347","author":"Habib","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.niox.2018.06.004_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004225","article-title":"Convergence of G protein-coupled receptor and S-nitrosylation signaling determines the outcome to cardiac ischemic injury","volume":"6","author":"Huang","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.niox.2018.06.004_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yjmcc.2017.09.010","article-title":"AGXT2: an unnegligible aminotransferase in cardiovascular and urinary systems","volume":"113","author":"Hu","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.niox.2018.06.004_bib35","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/ATVBAHA.110.222638","article-title":"Global dimethylarginine Dimethylaminohydrolase-1 (DDAH1) gene-deficient mice reveal that DDAH1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine","volume":"31","author":"Hu","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2018.06.004_bib36","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.108.819912","article-title":"Vascular endothelial-specific DimethylarginineDimethylaminohydrolase 1 deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine","volume":"120","author":"Hu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.105.167586","article-title":"ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/hh0102.102330","article-title":"Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview","volume":"90","author":"Ignarro","year":"2002","journal-title":"Circ. Res."},{"issue":"4 Pt 1","key":"10.1016\/j.niox.2018.06.004_bib39","first-page":"503","article-title":"Nitric oxide as a unique signaling molecule in the vascular system: a historical overview","volume":"53","author":"Ignarro","year":"2002","journal-title":"J. Physiol. Pharmacol."},{"issue":"9","key":"10.1016\/j.niox.2018.06.004_bib40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/nep.12493","article-title":"Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: the CKD-ROUTE study","volume":"20","author":"Iimori","year":"2015","journal-title":"Nephrology"},{"key":"10.1016\/j.niox.2018.06.004_bib41","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/01.CIR.99.24.3092","article-title":"Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase","volume":"99","author":"Ito","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib42","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.2353\/ajpath.2010.090614","article-title":"Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine","volume":"176","author":"Jacobi","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.niox.2018.06.004_bib43","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.3390\/ijms15045522","article-title":"Effect of lowering asymmetric dimethylarginine (ADMA) on vascular pathology in atherosclerotic ApoE-deficient mice with reduced renal mass","volume":"15","author":"Jacobi","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.niox.2018.06.004_bib44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000110092","article-title":"Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review","volume":"28","author":"Jacobi","year":"2008","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.niox.2018.06.004_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yjmcc.2012.12.003","article-title":"Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties","volume":"56","author":"Jeong","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.niox.2018.06.004_bib46","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1073\/pnas.0837428100","article-title":"Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice","volume":"100","author":"Jones","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2018.06.004_bib47","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/S0021-9258(18)62716-4","article-title":"Isolation and identification of N-G,N-G- and N-G,N'-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine","volume":"245","author":"Kakimoto","year":"1970","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.06.004_bib48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.V131170","article-title":"Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease","volume":"13","author":"Kielstein","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.niox.2018.06.004_bib49","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI200314172","article-title":"Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension","volume":"111","author":"Landmesser","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.niox.2018.06.004_bib50","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature14332","article-title":"Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.niox.2018.06.004_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bj3430209","article-title":"Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases","volume":"343","author":"Leiper","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.niox.2018.06.004_bib52","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1543","article-title":"Disruption of methylarginine metabolism impairs vascular homeostasis","volume":"13","author":"Leiper","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.niox.2018.06.004_bib53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.yjmcc.2004.05.005","article-title":"Premature death and age-related cardiac dysfunction in male eNOS-knockout mice","volume":"37","author":"Li","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.niox.2018.06.004_bib54","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.0000027109.14149.67","article-title":"Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase","volume":"106","author":"Lin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.niox.2016.02.006","article-title":"Effect of asymmetric dimethylarginine (ADMA) on heart failure development","volume":"54","author":"Liu","year":"2016","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2018.06.004_bib56","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/CIRCULATIONAHA.109.906818","article-title":"Oxidative stress regulates left ventricular PDE5 expression in the failing heart","volume":"121","author":"Lu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0092-8674(01)00423-8","article-title":"State of the arg: protein methylation at arginine comes of age","volume":"106","author":"McBride","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.niox.2018.06.004_bib58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/bj1540179","article-title":"Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit","volume":"154","author":"McDermott","year":"1976","journal-title":"Biochem. J."},{"key":"10.1016\/j.niox.2018.06.004_bib59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000087769","article-title":"Systemic nitric oxide production rate during hemodialysis and its relationship with nitric oxide-related factors","volume":"23","author":"Mochizuki","year":"2005","journal-title":"Blood Purif."},{"issue":"11","key":"10.1016\/j.niox.2018.06.004_bib60","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/ATVBAHA.112.300232","article-title":"Genetic and pharmacological inhibition of dimethylarginine dimethylaminohydrolase 1 is protective in endotoxic shock","volume":"32","author":"Nandi","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2018.06.004_bib61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0006-291X(87)90929-6","article-title":"Occurrence of a new enzyme catalyzing the direct conversion of NG,NG-dimethyl-L-arginine to L-citrulline in rats","volume":"148","author":"Ogawa","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2018.06.004_bib62","doi-asserted-by":"crossref","first-page":"14784","DOI":"10.1021\/bi00253a017","article-title":"Characterization of the inactivation of nitric oxide synthase by NG-methyl-L-arginine: evidence for heme loss","volume":"33","author":"Olken","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.niox.2018.06.004_bib63","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1159\/000063555","article-title":"Relationship between salt intake, nitric oxide and asymmetric dimethylarginine and its relevance to patients with end-stage renal disease","volume":"20","author":"Osanai","year":"2002","journal-title":"Blood Purif."},{"issue":"8","key":"10.1016\/j.niox.2018.06.004_bib64","doi-asserted-by":"crossref","first-page":"H1256","DOI":"10.1152\/ajpheart.00132.2013","article-title":"Endothelial cell transfusion ameliorates endothelial dysfunction in 5\/6 nephrectomized rats","volume":"305","author":"Pacurari","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.niox.2018.06.004_bib65","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.phrs.2009.07.016","article-title":"Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production","volume":"60","author":"Pope","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.niox.2018.06.004_bib66","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1523-1755.2002.00150.x","article-title":"Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin","volume":"61","author":"Raj","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.niox.2018.06.004_bib67","doi-asserted-by":"crossref","first-page":"597906","DOI":"10.1155\/2013\/597906","article-title":"Extreme elevations in blood pressure and all-cause mortality in a referred CKD population: results from the CRISIS study","volume":"2013","author":"Ritchie","year":"2013","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.niox.2018.06.004_bib68","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1074\/jbc.M109.091280","article-title":"Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production","volume":"285","author":"Rodionov","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.06.004_bib69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrneph.2011.31","article-title":"The role of asymmetric and symmetric dimethylarginines in renal disease","volume":"7","author":"Schwedhelm","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.niox.2018.06.004_bib70","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/eurheartj\/eht447","article-title":"AtheroRemo Consortium. Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality","volume":"35","author":"Sepp\u00e4l\u00e4","year":"2014","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.niox.2018.06.004_bib71","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/j.ajkd.2015.01.021","article-title":"CRIC study investigators. Serum fractalkine (CX3CL1) and cardiovascular outcomes and diabetes: findings from the chronic renal insufficiency cohort (CRIC) study","volume":"66","author":"Shah","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.niox.2018.06.004_bib72","first-page":"615","article-title":"Production of free methylarginines via the proteasome and autophagy pathways in cultured cells","volume":"4","author":"Shirakawa","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.niox.2018.06.004_bib73","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2125.1999.00940.x","article-title":"Ursodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease","volume":"47","author":"Sinisalo","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.niox.2018.06.004_bib74","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199904000-00020","article-title":"Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension","volume":"33","author":"Surdacki","year":"1999","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.niox.2018.06.004_bib75","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.ATV.0000136656.26019.6e","article-title":"Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress","volume":"24","author":"Suda","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2018.06.004_bib76","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/ATVBAHA.108.162073","article-title":"Dimethylargininedimethylaminohydrolase overexpression enhances insulin sensitivity","volume":"28","author":"Sydow","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.niox.2018.06.004_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048150","article-title":"Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertension","volume":"7","author":"Sydow","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2018.06.004_bib78","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.niox.2018.06.004_bib79","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI21968","article-title":"Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load","volume":"115","author":"Takimoto","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.niox.2018.06.004_bib80","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.105.537670","article-title":"Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease","volume":"112","author":"Tanaka","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib81","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/eurheartj\/ehn360","article-title":"Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure","volume":"29","author":"Tang","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.niox.2018.06.004_bib82","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/01.HYP.0000256764.86208.3d","article-title":"Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone","volume":"49","author":"Toth","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.niox.2018.06.004_bib83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/geno.2000.6262","article-title":"Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins","volume":"68","author":"Tran","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.niox.2018.06.004_bib84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1358836X0501000107","article-title":"DDAH gene and cardiovascular risk","volume":"10","author":"Valkonen","year":"2005","journal-title":"Vasc. Med."},{"key":"10.1016\/j.niox.2018.06.004_bib85","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2011.10.880","article-title":"Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial","volume":"59","author":"vonHaehling","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.niox.2018.06.004_bib86","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.11.006","article-title":"Proteasomal and lysosomal protein degradation and heart disease","volume":"71","author":"Wang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.niox.2018.06.004_bib87","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.freeradbiomed.2015.05.037","article-title":"S-nitrosylation of PDE5 increases its ubiquitin-proteasomal degradation","volume":"86","author":"Wang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2018.06.004_bib88","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/01.CIR.0000109692.16004.AF","article-title":"Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis","volume":"109","author":"Weis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.06.004_bib89","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1165\/rcmb.2006-0302SM","article-title":"Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells","volume":"36","author":"Wells","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.niox.2018.06.004_bib90","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1073\/pnas.93.13.6770","article-title":"Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury","volume":"93","author":"Xia","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2018.06.004_bib91","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00395-017-0644-z","article-title":"Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction","volume":"112","author":"Xu","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.niox.2018.06.004_bib92","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1097\/01.tp.0000183750.22675.be","article-title":"Endothelial functions improve with decrease in asymmetric dimethylarginine levels after renal transplantation","volume":"80","author":"Yilmaz","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.niox.2018.06.004_bib93","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2005.09.029","article-title":"The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine","volume":"47","author":"Yilmaz","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.niox.2018.06.004_bib94","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/heartjnl-2011-301372","article-title":"Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure","volume":"98","author":"Zairis","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.niox.2018.06.004_bib95","article-title":"DDAH1 deficiency attenuates endothelial cell cycle progression and angiogenesis","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2018.06.004_bib96","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.RES.0000264081.78659.45","article-title":"Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure","volume":"100","author":"Zhang","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2018.06.004_bib97","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1161\/ATVBAHA.110.215640","article-title":"Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt","volume":"31","author":"Zhang","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2018.06.004_bib98","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI0214442","article-title":"Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite","volume":"109","author":"Zou","year":"2002","journal-title":"J. Clin. Invest."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860318300983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860318300983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T23:20:43Z","timestamp":1661469643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860318300983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":98,"alternative-id":["S1089860318300983"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2018.06.004","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}